Search

everythinglearnresearchcommunity

for

Search:↓

Low-Level Laser Therapy (LLLT) is a safe and effective treatment for common hair loss, but more research is needed to find the best power and wavelength for treatment.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

Using developmental signaling pathways could improve adult wound healing by mimicking scarless embryonic healing.

The editorial concludes that while evidence-based medicine is crucial, doctors should also use their own experience and consider patient preferences in dermatology care.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

WAA-QOL measures impact of hair loss on women's well-being.

PRP injections help regrow hair, reduce hair loss, and increase hair thickness, but effects decrease without ongoing treatment.

New acne treatments show promise as alternatives to traditional therapies.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Blocking interferon-gamma might help treat various autoimmune diseases.

Topical therapies show promise for hair loss and acne treatment with minimal side effects.

Radiotherapy can cause skin fibrosis, which is often overlooked and needs better treatment and evaluation.

New drug shows promise for better hair growth in baldness treatment.

The hot-wire hair removal device is no better than shaving.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Dupilumab may cause hair loss in some patients with severe atopic dermatitis.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Honokiol might help reduce male skin aging by maintaining testosterone levels.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.

Exosomes show promise for tissue repair and regeneration with advantages over traditional cell therapies.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Ayurvedic hair treatments need scientific research to validate their effectiveness.